A United States perspective covers the growing market for complementary interventions to promote brain health or minimise dementia risk and/or symptoms. Health professionals are requested to help the public understand commercial conflicts of interest and the market forces behind the promotion of unproven treatments.
A Due Sense of Context and Uncertainties?
A quick glimpse at the readers’ replies indicates that there is little room for dogmatic one-sidedness in this debate.
Hellmuth, J. Rabinovici, GD. [and] Miller, BL. (2019). The rise of pseudomedicine for dementia and brain health. JAMA. January 25th 2019. [Epub ahead of print].